Published in Vaccine on October 14, 1999
Varicella vaccination--a critical review of the evidence. Arch Dis Child (2001) 1.52
Varicella vaccination in England and Wales: cost-utility analysis. Arch Dis Child (2003) 1.20
Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel. J R Soc Interface (2011) 1.01
Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health (2015) 0.96
Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting? Hum Vaccin Immunother (2013) 0.96
Economic evaluation of Varicella vaccination: results of a systematic review. Hum Vaccin Immunother (2013) 0.93
Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bull World Health Organ (2014) 0.91
Successes and challenges in varicella vaccine. Ther Adv Vaccines (2014) 0.86
Chickenpox. BMJ Clin Evid (2011) 0.78
Chickenpox. BMJ Clin Evid (2007) 0.76
Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med (1974) 1.48
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol (2001) 1.47
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol (1999) 1.45
Metastatic patterns of choroidal melanoma. Cancer (1974) 1.45
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol (1998) 1.45
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Hib disease must be prevented. Med J Aust (1994) 1.39
Hepatitis A epidemiology in Australia: national seroprevalence and notifications. Med J Aust (2001) 1.38
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol (1997) 1.34
Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients. Am J Med Sci (1976) 1.32
Clotrimazole (Bay b 5097): in vitro and clinical pharmacological studies. Antimicrob Agents Chemother (1972) 1.28
Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet (1974) 1.27
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25
Homoeopathic vaccination. What does it mean? Immunisation Interest Group of the Royal Alexandra Hospital for Children. Med J Aust (1994) 1.20
Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate. Aust N Z J Obstet Gynaecol (1995) 1.18
Varicella vaccination in Australia. J Paediatr Child Health (2005) 1.17
National study of adverse reactions after vaccination with bacille Calmette-Guérin. Clin Infect Dis (2002) 1.16
The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997. Commun Dis Intell (1999) 1.15
Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy. Am J Clin Oncol (1995) 1.15
Myxoid liposarcoma. Experience with chemotherapy. Cancer (1994) 1.13
Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery (1995) 1.08
Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas. Cancer (2001) 1.01
Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil. Lancet (1976) 0.99
Impact of the Australian Measles Control Campaign on immunity to measles and rubella. Epidemiol Infect (2001) 0.98
Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer of the Dukes' C classification. Preliminary clinical results. Cancer (1975) 0.97
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol (2000) 0.96
The Australian Measles Control Campaign, 1998. Bull World Health Organ (2001) 0.96
The natural history of resectable metastatic melanoma (Stage IVA melanoma). Cancer (1982) 0.96
Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule. Cancer Res (1984) 0.94
Surgical strategy for the treatment of medullary thyroid carcinoma. Ann Surg (1999) 0.93
The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiol Infect (2003) 0.92
Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia. J Clin Invest (1974) 0.91
Immunisation coverage in Australian children: a systematic review 1990-1998. Commun Dis Intell (1999) 0.91
Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep (1980) 0.90
A short history of vaccination in Australia. Med J Aust (2001) 0.90
Immunodiagnosis of acute leukemia: detection of residual disease. J Natl Cancer Inst (1974) 0.90
Chemotherapy of malignant major salivary gland neoplasms: a 25-year review of M. D. Anderson Hospital experience. Cancer (1977) 0.90
Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomas. Invest New Drugs (1998) 0.89
Plotting the demise of congenital rubella and varicella. Aust N Z J Public Health (1996) 0.88
BACON (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients. Cancer (1976) 0.87
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative. Cancer Res (1978) 0.87
Chemotherapy for metastatic Merkel cell carcinoma. Review of the M.D. Anderson Hospital's experience. Cancer (1988) 0.86
The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma. Cancer (1978) 0.86
A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults. Vaccine (2000) 0.86
Vaccines and the cold chain: is it too hot ... or too cold? Med J Aust (1999) 0.85
Endocrine carcinoma of the skin (Merkel cell carcinoma). Pathol Annu (1984) 0.85
Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma. Blood (1977) 0.85
Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study. J Clin Oncol (1984) 0.85
Varicella-zoster virus infection in Australia. Aust N Z J Public Health (1998) 0.84
Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type. Am J Med (1983) 0.84
Horizontal transmission of hepatitis B in a children's day-care centre: a preventable event. Aust N Z J Public Health (1997) 0.84
Accelerated schedule of hepatitis B vaccination in high-risk youth. J Paediatr Child Health (1996) 0.84
Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella. Commun Dis Intell (1998) 0.83
Cytogenetic remission in acute transformation of chronic granulocytic leukaemia. Br Med J (1969) 0.82
Hepatitis A vaccination options for Australia. J Paediatr Child Health (2003) 0.82
Rethinking contraindications to vaccination. Med J Aust (1998) 0.82
Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer. Ann N Y Acad Sci (1976) 0.82
Rotavirus gastroenteritis: impact on young children, their families and the health care system. Med J Aust (1997) 0.82
Phase I study of maytansine using a 3-day schedule. Cancer Treat Rep (1978) 0.81
Measles control in Australia. Report of the Measles Control in Australia Workshop, 5 November 1997. Commun Dis Intell (1998) 0.81
Treatment of acute leukemia with 5-azacytidine (NSC-102816). Cancer Chemother Rep (1974) 0.81
Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapy. J Surg Oncol (1981) 0.81
Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer (1984) 0.81
Vaccination of children following a previous hypotonic-hyporesponsive episode. J Paediatr Child Health (1999) 0.80
Phase I clinical evaluation of anguidine. Cancer Treat Rep (1978) 0.80
Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiol Infect (2003) 0.80
Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG. Br Med J (1976) 0.80
Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer (2001) 0.79
Pneumococcal disease in Australia. Commun Dis Intell (2000) 0.79
Late intensification therapy for acute leukemia in remission. Chemotherapy and immunotherapy. JAMA (1976) 0.79
Medullary thyroid carcinoma. Curr Ther Endocrinol Metab (1997) 0.78
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG. Cancer (1979) 0.78
Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid. Cancer Res (1979) 0.78
Parent and general practitioner preferences for infant immunisation. Reactogenicity or multiple injections? Aust Fam Physician (1999) 0.78
A phase II evaluation of methyl CCNU and actinomycin D in the treatment of advanced sarcomas in adults. Cancer (1981) 0.78
Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck. Cancer Treat Rep (1976) 0.77
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma. J Clin Oncol (1994) 0.77
A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors. J Neurooncol (1983) 0.77
Phase I clinical studies with gallium nitrate. Cancer Treat Rep (1978) 0.77
Acute thrombocytopenic purpura due to quinine sensitivity. Med J Aust (1969) 0.77
A phase II study of peptichemio in advanced breast cancer. Cancer (1980) 0.77
A phase II trial of PCNU in patients with malignant melanoma and central nervous system metastases. Am J Clin Oncol (1985) 0.77
Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer (Dukes' class C): prolongation of disease-free interval and survival. Cancer (1977) 0.76
Results of a phase II study of maytansine in patients with breast carcinoma and melanoma. Cancer Treat Rep (1979) 0.76
Cytotoxic chemotherapy in adrenal cortical carcinoma. Cancer Treat Rep (1981) 0.76
Sequential chemoimmunotherapy of colorectal cancer: evaluation of methotrexate, Baker's Antifol and levamisole. Cancer (1978) 0.76
Phase II Study of Paclitaxel in Patients With Soft Tissue Sarcomas. Sarcoma (1997) 0.76
Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer. Cancer (1978) 0.76
Immunotherapy: its possible application in the management of large-bowel cancer. Am J Dig Dis (1974) 0.76
Phase-I trial of intracarotid BCNU and cisplatin in patients with malignant intracerebral tumors. Cancer Drug Deliv (1984) 0.76
Chemotherapy for adenocarcinoma of the lung with 5-fluorouracil, cyclophosphamide, and CCNU (FCC). Cancer (1979) 0.76
Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG. Cancer (1979) 0.75
Congenital rubella and diabetes mellitus. Diabetologia (2008) 0.75
Congenital varicella. J Paediatr Child Health (1995) 0.75
Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma. Cancer (1980) 0.75
Two dose MMR vaccine schedule. J Paediatr Child Health (1994) 0.75
Gregg and congenital rubella: lessons from history and clinical research. Aust N Z J Ophthalmol (1991) 0.75
Chemoimmunotherapy of metastatic large bowel cancer: nonspecific stimulation with BCG and levamisole. Cancer (1977) 0.75
Mitotane failure in adrenocortical cancer: where next? Cancer (1993) 0.75
Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma. Cancer Treat Rep (1976) 0.75